Alleguard

Overview
Cold Chain Innovation?
Product stageSegments
Minimum Viable Product
?
Temperature-sensitive packaging
?

Allerguard is a company focused on developing innovative solutions for allergy sufferers. The company's flagship product is an airborne allergen detection system that scans entire plates of food, identifying allergens in parts per billion, down to the safest allowable amount. This technology aims to provide a more comprehensive and user-friendly approach to allergen detection compared to traditional methods that require food sampling and waiting for analysis. Allerguard's device is designed to improve the dining experience for allergy sufferers by allowing them to feel more normal when eating out. The company utilizes artificial intelligence, advanced materials, and nanotechnology to enhance its products' capabilities. In addition to its food allergen detection system, Allerguard has developed other allergy-related products. These include AllerGuard Express, a fast-acting dietary supplement for seasonal sinus and respiratory wellness, which was introduced in January 2014. AllerGuard Express is clinically proven to address year-round exposure to respiratory challenges and works within 15 minutes of exposure without a load period. The company has also created anti-allergy bedding products, such as duvets and pillows, designed to prevent dust mites and other allergens from penetrating the fabric.

Key customers and partnerships

Allerguard's products cater to a wide range of customers, including individuals with food allergies, seasonal allergy sufferers, and those seeking hypoallergenic bedding solutions. The company's AllerGuard Express product is available to leading marketers of dietary supplements in chewable tablet form. Allerguard has also partnered with Stragen healthcare Group, based in Geneva, Switzerland, for the development and manufacture of AllerGuard Express. The company's anti-allergy bedding products have been tested and certified by the Danish Asthma and Allergy Association and the Danish Medicines Agency, demonstrating their commitment to quality and safety for allergy sufferers.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Kibbutz Dalia ISR
Founded year:
2017
Employees:
1-10
IPO status:
Private
Total funding:
USD 2.2 mn
Last Funding:
USD 1.5 mn (Seed; Oct 2019)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.